Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sectra ABCHIX:SECTBS 98 Earnings Yield (Joel Greenblatt) % is 1.55% as of Apr. 2026, which is 2% below its 10-year median of 1.58. GuruFocus rates CHIX:SECTBS with a GF Score™ of 98/100 and a GF Value™ of kr311.12 (Modestly Undervalued). Among 852 Medical Devices & Instruments companies, Sectra AB ranks better than 51.53% on this metric.
Sectra AB's Enterprise Value for the quarter that ended in Apr. 2026 was kr49,942 Mil.
Sectra AB's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 was kr711 Mil. Sectra AB's Earnings Yield (Joel Greenblatt) for the quarter that ended in Apr. 2026 was 1.55%.
The historical rank and industry rank for Sectra AB's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
CHIX:SECTBs'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 0.86 Med: 1.58 Max: 4.3
Current: 1.46
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Sectra AB was 4.30%. The lowest was 0.86%. And the median was 1.58%.
CHIX:SECTBs's Earnings Yield (Joel Greenblatt) % is ranked better than 51.53% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 0.83
vs CHIX:SECTBs: 1.46
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Sectra AB's Forward Rate of Return (Yacktman) % for the quarter that ended in Apr. 2026 was 17.13%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Sectra AB (CHIX:SECTBs) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Sectra AB Earnings Yield (Joel Greenblatt) % Related Terms
Sectra AB Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Sectra AB's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sectra AB Earnings Yield (Joel Greenblatt) % Chart
For the Medical Devices subindustry, Sectra AB's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sectra AB Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Sectra AB's Earnings Yield (Joel Greenblatt) % falls into.
Sectra AB Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Sectra ABs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Apr. 2026 is calculated as
Sectra AB's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr711 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 1.55% mean?
Sectra AB (CHIX:SECTBS) has a Earnings Yield (Joel Greenblatt) % of 1.55% as of Apr. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Sectra AB and its competitors. This is near median its historical median of 1.58. Over the past decade, Sectra AB's Earnings Yield (Joel Greenblatt) % has ranged from 0.86 to 4.30. According to the industry distribution chart, Sectra AB ranks #413 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 48.5%.
Is Sectra AB's Earnings Yield (Joel Greenblatt) % too high?
Sectra AB's current Earnings Yield (Joel Greenblatt) % of 1.55% is near median its 10-year median of 1.58. Over the past 10 years, this metric has ranged from a low of 0.86 to a high of 4.30. The Medical Devices & Instruments industry median Earnings Yield (Joel Greenblatt) % is 0.83. Sectra AB's value of 1.55% is 86.7% above this industry median. Based on the distribution chart, Sectra AB ranks #413 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sectra AB has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's Earnings Yield (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #413 out of 852 companies for Earnings Yield (Joel Greenblatt) %. This puts Sectra AB in the upper half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 0.83. Sectra AB's value of 1.55% is 86.7% above this benchmark. Historically, Sectra AB's own Earnings Yield (Joel Greenblatt) % has ranged from 0.86 to 4.30 over the past decade. While the company's 10-year median is 1.58 vs. the industry median of 0.83, Sectra AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 0.83, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sectra AB's current Earnings Yield (Joel Greenblatt) % of 1.55% is 86.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Sectra AB and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 0.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current Earnings Yield (Joel Greenblatt) % is 1.55%, which is near median its own 10-year median of 1.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (CHIX:SECTBS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr311.12, compared to a current price of kr277.30 — trading 10.9% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 1.55%, which is near median its 10-year median of 1.58 and 86.7% above the Medical Devices & Instruments industry median of 0.83. Sectra AB's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Sectra AB (CHIX:SECTBS), the current Earnings Yield (Joel Greenblatt) % is 1.55% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (CHIX:SECTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of kr277.30 is trading 10.9% below its estimated GF Value™ of kr311.12.
GuruFocus considers Sectra AB to be Modestly Undervalued.
Key valuation signals for CHIX:SECTBS:
Earnings Yield (Joel Greenblatt) %: 1.55% (near median its 10-year median of 1.58)
GF Value™: kr311.12 vs. price of kr277.30 (10.9% below fair value)
Industry Position: 86.7% above the Medical Devices & Instruments median (#413 of 852)
No single metric tells the full story. See the CHIX:SECTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
98GF Score
Get the complete analysis for CHIX:SECTBS
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SECTBS has been successfully added to your 
